FOXO Technologies, a technology company applying epigenetic science and AI to modernize the life insurance industry, agreed to go public via a SPAC merger with Delwinds Insurance Acquisition, a special purpose acquisition company, in a $369m deal. “Our goal is to modernize life insurance by making advances in longevity science fundamental to the product itself. This transaction is transformative in our effort to support the industry’s effort to modernize in the face of accelerating advances in science and technology to reach more consumers at a time when interest in life insurance is at all-time highs,” Jon Sabes, FOXO Founder and CEO.